Background: In recent years we have systematically explored the skin whenever sarcoidosis was suggested and we have observed with increasing frequency the presence of granulomatous cutaneous lesions of sarcoidosis involving the knees.
Objective: We sought to evaluate the specific cutaneous lesions of sarcoidosis involving the knees.
Methods: A total of 18 patients with biopsy-proven specific cutaneous sarcoidosis predominantly involving the knees were included in the study. Biopsy specimens were evaluated under polarized light.
Results: Of these cases, 4 corresponded to scar-sarcoidosis, 1 to plaque-type sarcoidosis, and 13 were an admixture of papules and minute scars frequently associated with erythema nodosum (papular sarcoidosis of the knees). Foreign particles were observed in 10 of 13 patients with papular sarcoidosis.
Conclusion: Papular sarcoidosis of the knees can be considered a frequent form of cutaneous sarcoidosis, mainly observed in acute forms of the disease, and frequently associated with erythema nodosum.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1067/mjd.2003.490 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Periorificial dermatitis in infants and preschoolers - a narrative review.
Eur J Pediatr
January 2025
Department of Dermatology & Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany.
Periorifical dermatitis (POD) is a papular, chronic inflammatory skin disease commonly seen in women in their 2nd to 4th decade of life. The major differential diagnosis is persistent acne. In children, POD is less common than in adults.
View Article and Find Full Text PDFEfficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a single-centre trial.
Lancet Rheumatol
February 2024
Department of Dermatology, Medical University of Vienna, Vienna, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Article Synopsis
- Sarcoidosis is an inflammatory disease causing granulomas in various organs, and its cause is unknown; the study investigates sirolimus, an mTOR inhibitor, as a potential treatment for cutaneous sarcoidosis.* -
- The research was conducted at the Vienna General Hospital, enrolling patients with persistent and glucocorticoid-resistant cutaneous sarcoidosis, and involved two phases: a double-blind topical treatment followed by systemic treatment.* -
- The main goal was to measure changes in the Cutaneous Sarcoidosis Activity and Morphology Index (CSAMI) after treatments, while also monitoring for adverse effects related to sirolimus.*
Polymorphous Cutaneous Sarcoidosis With Excellent Response to Minocycline.
Cureus
October 2023
Dermatology, Rush University Medical Center, Chicago, USA.
Sarcoidosis is notorious for producing a wide variety of skin lesions, which are categorized as either specific or nonspecific. The specific lesions include primary morphologies ranging from micropapules to subcutaneous nodules. Nonspecific skin lesions include associated conditions like erythema nodosum, calcinosis cutis, and prurigo.
View Article and Find Full Text PDFCase Report: Methotrexate and hydroxychloroquine in combination for the treatment of NOD2-mutation-associated Blau syndrome.
Front Immunol
November 2023
Department of Dermatology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Mutations in nucleotide binding oligomerization domain containing 2 receptor (NOD2) are associated with Blau syndrome (also known as early-onset sarcoidosis)-a rare autosomal dominant, chronic granulomatous disease that typically presents before 5 years of age. Blau syndrome is characterized by the clinical triad of arthritis, granulomatous dermatitis, and recurrent uveitis. Here, we report a case of NOD2-mutation-associated early-onset sarcoidosis in which a combination of methotrexate and hydroxychloroquine was used to achieve improvement in arthritis, granulomatous dermatitis, and uveitis.
View Article and Find Full Text PDFSarcoid-like Reactions to Immune Checkpoint Inhibitors.
Actas Dermosifiliogr
January 2024
Servicio de Dermatología, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, España.
Immune checkpoint inhibitors (ICIs) can cause immune-mediated cutaneous adverse events, including sarcoid-like reactions. The aim of this study was to retrospectively analyze clinical and histologic data from patients who developed cutaneous sarcoid-like reactions between 2019 and 2022 while under treatment with ICIs. We studied 7 patients (6 women and 1 man) with a median age of 65years.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!